$38.00
Today
as of Sep 4, 16:53 ET
Last 30 days
Recent Press Releases & News
Senior Health, Home Health & Hospice Stocks Q2 Results: Benchmarking The Pennant Group (NASDAQ:PNTG)
Pennant Group to Participate in the 2026 Jefferies Healthcare Services Conference
3 Reasons to Avoid PNTG and 1 Stock to Buy Instead
Overview
52-week range
$22
$43
77% of range
Avg surprise (last 3)
+12.7%
Avg reaction (last 2)
+1.9%
100% positive
Latest IV / EM
89%
EM ±13.9% · $40 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $0.25 | — | — | — | — | financials |
| Wed May 6, 2026 | Mar/2026 | $0.27 | $0.26 | +3.9% | +22.7% | +3.4% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.17 | — | — | — | — | financials |
| Wed Aug 6, 2025 | Jun/2025 | $0.22 | $0.21 | +4.8% | — | — | earnings |
| Tue May 6, 2025 | Mar/2025 | $0.22 | $0.17 | +29.4% | — | +0.4% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.20 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.18 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.16 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.15 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.09 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $0.06 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $298M | $285M | — | $229M | $220M | $210M | — | $181M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $17M | $17M | — | $10M | $12M | $13M | — | $11M |
| Net income | $9M | $9M | — | $6M | $7M | $8M | — | $6M |
| EPS (diluted) | $0.25 | $0.24 | — | $0.17 | $0.20 | $0.22 | — | $0.20 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $15M | $5M | $17M | $2M | $14M | $5M | $24M | $4M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $184M | $153M | $167M | $114M | $127M | $124M | $123M | $102M |
| Total assets | $1.04B | $956M | $968M | $754M | $751M | $744M | $680M | $647M |
| Long-term debt | $192M | $165M | $169M | $26M | $37M | $52M | $0 | $109M |
| Total liabilities | $633M | $567M | $594M | $411M | $418M | $421M | $368M | $459M |
| Total equity | $404M | $389M | $374M | $343M | $334M | $323M | — | $187M |